Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Good morning. Today, we read about the implications of mRNA funding cuts on national security, see layoffs at gene-editing player Tune Therapeutics, and more.
Why mRNA funding cuts are a national security issue
Health secretary Robert F. Kennedy Jr.’s abrupt decision to end federal funding for mRNA vaccine development has sparked sharp backlash from scientists and national security experts alike, STAT’s Helen Branswell writes. They say the move leaves the U.S. dangerously underprepared for not only future pandemics but also the threat of bioterrorism.
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.
Already have an account? Log in
To read the rest of this story subscribe to STAT+.
